1607 Capital reports 4.08% stake in EMF fund
1607 Capital Partners, LLC filed an amended Schedule 13G reporting its ownership in Templeton Emerging Markets Fund.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
1607 Capital Partners, LLC filed an amended Schedule 13G reporting its ownership in Templeton Emerging Markets Fund. As of 12/31/2025, it beneficially owned 609,636 shares, representing 4.08% of the closed-end fund’s outstanding shares. 1607 Capital reports sole voting and sole dispositive power over all of these shares, with no shared power. The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the fund.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does 1607 Capital Partners report in its Schedule 13G/A for EMF?
What percentage of Templeton Emerging Markets Fund does 1607 Capital own?
Is 1607 Capital’s stake in EMF considered passive or for control purposes?
What type of security is reported for Templeton Emerging Markets Fund (EMF)?
When is the ownership information for 1607 Capital’s EMF stake effective?
AI-generated analysis. How Rhea-AI works. Not financial advice.